Dear patients and caregivers,
The COVID-19 pandemic has caused understandable concern for many of our patients. I want to reassure you that the Myeloma Center is dedicated to continuing to provide outstanding care to all our patients and that those in need of immediate therapy or evaluation will continue to be seen.
The Myeloma Center as the premier clinical program within the Winthrop P. Rockefeller Cancer Institute will implement the Cancer Center Program of screening and triage of suspected exposed patients. This approach will ensure the safety of myeloma patients and their families.
Patients who receive their regular chemotherapy and other treatments in infusion 4 should continue to do so and we continue to accept newly referred patients with myeloma, lymphoma, Castleman disease, Waldenstrom’s disease and amyloidosis.
Your care team will be making individualized treatment decisions. Non-urgent transplant and combination chemotherapy treatments will be delayed, but those with high-risk disease or other concerns will continue to proceed with therapy.
Our physicians and nurse practitioners are reviewing the upcoming appointments of all patients to determine whether they can have their appointments safely delayed. All patients who have their appointment delayed will get a call from their doctor or nurse practitioner to discuss ongoing treatment or monitoring plans, answer any questions and plan for your next visit.
Please let us know if you feel your appointment was incorrectly delayed and your existing appointment will be kept or re-booked. Our team of doctors, nurse practitioners, nurses and other health care workers will continue to care for you during your myeloma journey. We will be available to answer any questions and provide teleconsultation with you or your local health care provider.
We recommend you call us before your appointments if you or your caregiver are ill with any type of respiratory symptoms. The same applies if you have been in contact with a COVID-19 infected individual. The number of visitors will be restricted on F7 to one per patient, and no overnight visitors will be allowed expect for patients undergoing stem cell transplants.
We look forward to seeing you. However, if you choose not to come, please call to cancel or reschedule your appointments at 501-686-8230. Please follow up with your local oncologist, and send myeloma markers as scheduled for ongoing monitoring.
This pandemic will subside and the Myeloma Center is committed to supporting you during these trying times.
Frits van Rhee, M.D., Ph.D.
Clinical Director of the Myeloma Center
University of Arkansas for Medical Sciences